Braveheart Investment Group

Founded in 1997, Braveheart Investment Group is a venture capital firm based in Barnsley, United Kingdom. It specializes in seed to growth stage investments in unquoted emerging companies across various sectors, with a focus on technology, manufacturing, and healthcare industries. The firm typically invests between £0.01 million to £10 million, taking minority stakes and holding investments for two to five years.

Trevor Brown

CEO

Past deals in Scotland

mLED

Venture Round in 2012
mLED Limited is a developer and manufacturer of gallium nitride micropixellated light-emitting diode (LED) array systems, headquartered in Glasgow, United Kingdom. The company specializes in micro-LED technology, providing system integrators with the tools necessary to create both prototype and production units for various sectors, including industrial, medical, and commercial applications. mLED's technology supports customized light patterns based on pixel layout and addressing, as well as tailored wavelengths, offering solutions that can deliver continuous pulsed or modulated light patterns.

AppShare

Series D in 2011
AppShare is a technology company that emerged from the University of Strathclyde in 2008, specializing in web application technology. It offers a unique collaboration platform known as ePlace, which facilitates secure communication and application sharing across various locations. AppShare's development is protected by patents, positioning it as a leader in scalable and secure collaborative solutions. By leveraging its innovative technology, AppShare aims to significantly enhance web collaboration on a global scale.

Conjunct

Series C in 2011
Conjunct Ltd. is a company based in Livingston, United Kingdom, that specializes in designing and developing advanced transceiver modules utilizing Fibre-Lyte technology for high-speed optical communications. Established in 2004, Conjunct's innovative Fibre-Lyte glass substrate technology encapsulates optical waveguides, enabling the production of specialized thin film metallization. The company offers a range of products, including 4x25G and 4x10G transceiver modules, as well as 300G and 400G transceivers, which are applicable in various fields such as active optical cables, data storage, high-performance computing I/O interfaces, and ASIC/FPGA optical interfaces. Additionally, Conjunct provides Dynamic Serial Optical Interconnect (DSOI) solutions that facilitate the integration of optics into FPGA-based systems, serving diverse applications from cable extension to digital cinema. The company also extends its expertise through transceiver design and consultancy services, contributing to enhanced connectivity in storage area networks, local area networks, and network-attached storage systems.

AppShare

Private Equity Round in 2010
AppShare is a technology company that emerged from the University of Strathclyde in 2008, specializing in web application technology. It offers a unique collaboration platform known as ePlace, which facilitates secure communication and application sharing across various locations. AppShare's development is protected by patents, positioning it as a leader in scalable and secure collaborative solutions. By leveraging its innovative technology, AppShare aims to significantly enhance web collaboration on a global scale.

mLED

Seed Round in 2010
mLED Limited is a developer and manufacturer of gallium nitride micropixellated light-emitting diode (LED) array systems, headquartered in Glasgow, United Kingdom. The company specializes in micro-LED technology, providing system integrators with the tools necessary to create both prototype and production units for various sectors, including industrial, medical, and commercial applications. mLED's technology supports customized light patterns based on pixel layout and addressing, as well as tailored wavelengths, offering solutions that can deliver continuous pulsed or modulated light patterns.

Conjunct

Series B in 2010
Conjunct Ltd. is a company based in Livingston, United Kingdom, that specializes in designing and developing advanced transceiver modules utilizing Fibre-Lyte technology for high-speed optical communications. Established in 2004, Conjunct's innovative Fibre-Lyte glass substrate technology encapsulates optical waveguides, enabling the production of specialized thin film metallization. The company offers a range of products, including 4x25G and 4x10G transceiver modules, as well as 300G and 400G transceivers, which are applicable in various fields such as active optical cables, data storage, high-performance computing I/O interfaces, and ASIC/FPGA optical interfaces. Additionally, Conjunct provides Dynamic Serial Optical Interconnect (DSOI) solutions that facilitate the integration of optics into FPGA-based systems, serving diverse applications from cable extension to digital cinema. The company also extends its expertise through transceiver design and consultancy services, contributing to enhanced connectivity in storage area networks, local area networks, and network-attached storage systems.

NXVISION

Venture Round in 2009
NXVision, based in Dunfermline, Scotland, was founded in August 2006 as Inxstor Ltd. The company specializes in digital media software, focusing on innovative solutions for video content delivery. It has developed proprietary technology that enables any Internet-connected device or mobile phone to access and display content from a home set-top box or Internet-connected television. NXVision has quickly established itself as a prominent supplier of set-top box applications, offering comprehensive place-shifting and sideloading solutions that ensure secure and efficient video streaming.

Pyreos

Venture Round in 2009
Pyreos Limited is a UK-based company specializing in the development of infrared sensor array products. Founded in 2007 and headquartered in Edinburgh, Pyreos utilizes patented thin film pyro-electric ceramic technology to create a range of infrared sensors applicable in various fields. The company's product offerings include bare die arrays, packaged components, and custom arrays designed for motion and occupancy detection, flame detection, people counting, gas analysis, spectroscopy, and infrared camera applications. Pyreos focuses on three primary markets—food safety, gas detection, and fuel/oil condition monitoring—where its compact and high-performance sensors operate in the mid-infrared spectrum, allowing for precise identification of material molecular compositions.

Biopta

Funding Round in 2008
Biopta Ltd. is a contract research organization based in Glasgow, United Kingdom, specializing in human tissue-based services for the pharmaceutical industry. Founded in 2002, the company utilizes ethically donated residual human tissue from surgeries to predict drug activity prior to clinical trials. Biopta provides a range of services, including laboratory and comparative pharmacology, clinical biopsies, and both in-vitro and ex-vivo techniques. Their expertise spans several therapeutic areas, offering services related to cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary functions. In addition, Biopta maintains a catalogue of human functional tissue assays, which includes various standard assays. The organization operates laboratories in Glasgow and Maryland and functions as a subsidiary of ReproCELL, Inc. since December 2015.

Spiral Gateway

Series C in 2008
Spiral Gateway is a fabless semiconductor chip vendor with products that are designed to enhance flexibility and performance in the Image Signal Processing (ISP) market. The company was formed in 2004 as a spinout from the University of Edinburgh and holds exclusive rights to RICA (Reconfigurable Instruction Cell Architecture), a novel processing architecture and associated tool chain. This technology has the potential to achieve cost & performance points for existing signal processing functions, directly comparable with fixed function custom hardware, whilst offering the significant additional benefit of high degrees of flexibility through software programmability.

Pyreos

Convertible Note in 2007
Pyreos Limited is a UK-based company specializing in the development of infrared sensor array products. Founded in 2007 and headquartered in Edinburgh, Pyreos utilizes patented thin film pyro-electric ceramic technology to create a range of infrared sensors applicable in various fields. The company's product offerings include bare die arrays, packaged components, and custom arrays designed for motion and occupancy detection, flame detection, people counting, gas analysis, spectroscopy, and infrared camera applications. Pyreos focuses on three primary markets—food safety, gas detection, and fuel/oil condition monitoring—where its compact and high-performance sensors operate in the mid-infrared spectrum, allowing for precise identification of material molecular compositions.

NXVISION

Venture Round in 2007
NXVision, based in Dunfermline, Scotland, was founded in August 2006 as Inxstor Ltd. The company specializes in digital media software, focusing on innovative solutions for video content delivery. It has developed proprietary technology that enables any Internet-connected device or mobile phone to access and display content from a home set-top box or Internet-connected television. NXVision has quickly established itself as a prominent supplier of set-top box applications, offering comprehensive place-shifting and sideloading solutions that ensure secure and efficient video streaming.

Edinburgh Robotics

Series B in 2007
Edinburgh Robotics Limited was founded in 2005 by Joe Halliwell and Nils Roeder, two former researchers who maintain their close relationship with the University of Edinburgh. Edinburgh Robotics built their development platform to integrate experiences from mobile robotics to help accelerating intelligent system and robotic application development.

NiTech Solutions

Venture Round in 2007
NiTech Solutions Ltd. is a company based in Edinburgh, United Kingdom, specializing in the design and provision of continuous oscillatory baffled reactors and tubular reactors. Founded in 2003, it focuses on enhancing processes in crystallization, biodiesel production, hydrogenation, polymerization, and the synthesis of pharmaceutical active ingredients. The company excels in mixing technologies applicable to liquid-liquid, liquid-solid, liquid-gas, and liquid-solid-gas processes across various sectors, including chemicals, pharmaceuticals, biotechnology, waste management, and food and beverages. By leveraging innovative baffled reactor technology, NiTech Solutions aims to facilitate the transition from batch to continuous processing, thereby improving operational efficiency, reducing costs, minimizing energy consumption, and enhancing product quality for its clients. The team comprises experts in process design, chemistry, chemical engineering, and reaction engineering, which allows the company to successfully deliver significant process improvements and develop innovative solutions tailored to client needs.

Edinburgh Robotics

Series A in 2006
Edinburgh Robotics Limited was founded in 2005 by Joe Halliwell and Nils Roeder, two former researchers who maintain their close relationship with the University of Edinburgh. Edinburgh Robotics built their development platform to integrate experiences from mobile robotics to help accelerating intelligent system and robotic application development.

NXVISION

Venture Round in 2006
NXVision, based in Dunfermline, Scotland, was founded in August 2006 as Inxstor Ltd. The company specializes in digital media software, focusing on innovative solutions for video content delivery. It has developed proprietary technology that enables any Internet-connected device or mobile phone to access and display content from a home set-top box or Internet-connected television. NXVision has quickly established itself as a prominent supplier of set-top box applications, offering comprehensive place-shifting and sideloading solutions that ensure secure and efficient video streaming.

Biopta

Series A in 2004
Biopta Ltd. is a contract research organization based in Glasgow, United Kingdom, specializing in human tissue-based services for the pharmaceutical industry. Founded in 2002, the company utilizes ethically donated residual human tissue from surgeries to predict drug activity prior to clinical trials. Biopta provides a range of services, including laboratory and comparative pharmacology, clinical biopsies, and both in-vitro and ex-vivo techniques. Their expertise spans several therapeutic areas, offering services related to cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary functions. In addition, Biopta maintains a catalogue of human functional tissue assays, which includes various standard assays. The organization operates laboratories in Glasgow and Maryland and functions as a subsidiary of ReproCELL, Inc. since December 2015.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.